By REUTERS
A federal jury on Thursday ordered Gilead Sciences to pay for infringing two Merck patents related to a lucrative cure for hepatitis C.
Published: March 25, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1LLcQgL
from WordPress http://ift.tt/1RpEHSX
via Hadi Aboukhater
No comments:
Post a Comment